Esketamine may solve depression need, but not be cost-effective - STAT

Esketamine may solve depression need, but not be cost-effective - STAT

STAT Plus: J&J’s new esketamine drug for depression may solve an unmet need, but may not be cost-effective

By ED SILVERMAN

STAT

Esketamine is a new option for depression, but a preliminary analysis says the price would have to be shaved by 25 percent to be cost-effective.

READ MORE